To include your compound in the COVID-19 Resource Center, submit it here.

Actimmune: Phase II

In a double-blind Phase III trial in 330 patients with IPF, Actimmune interferon gamma-1b gave about a 10% relative

Read the full 195 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE